New Partnership Agreement

Transasia Bio-Medicals Ltd., new Vircell's exclusive partner in India

On such a special occasion like Hindi’s Gudi / Padwa / Telegu New Year's day (last Monday, April 5th) TRANSASIA’s Founder and Managing Director, Mr. Suresh Vazirani, signed with Mr. Julio Rodriguez  –International Sales & Marketing Director, representing Vircell- an exclusive distribution agreement which appoints TRANSASIA as our distinguished partner in India. The top Management of this leading international IVD company (Dr. Gurumukh Advani -President-, Mr. Rajesh Patel -Vice President Sales & Marketing-, Mr. Saurabh Gupta -Senior Manager Business Development (Immunology); Mr. V P Nair -Chief Operating Officer-. Dr. A De -Sr. Vice President R&D) and our R&D Director, Dr. Jose Rojas, joined this signature act to show their full support. Both companies expect to maximize this "strategic alliance" and explore new levels of cooperation.

At Vircell, we consider this memorable date as the beginning of a great business relationship that will endure in time, generate value for all parties as well as strengthen our local presence in India. Ultimately, we will provide the local scientific community with the best and most adequate IVD products to diagnose esoteric infectious diseases like pneumonia (one of the two major causes of death in children in India), and other endemic diseases like human brucellosis, influenza, STD, etc. New projects, customized products and services will be evaluated by both management teams to combine value chains and maximize business opportunities. Our aim is to meet the end-user’s needs with outstanding and accurate IVD tools that help them prescribe more efficient treatments. As a result, if our alliance contributes to improve patient’s quality of life in India, our mission will be fully accomplished.

TRANSASIA's website: http://www.transasia.co.in/

Press Release on India PRwire: Transasia announces new partnership and launch of new products in India